Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study.
Chakraborty S, Filippi CG, Wong T, Ray A, Fralin S, Tsiouris AJ, Praminick B, Demopoulos A, McCrea HJ, Bodhinayake I, Ortiz R, Langer DJ, Boockvar JA. Chakraborty S, et al. Among authors: wong t. J Neurooncol. 2016 Jul;128(3):405-15. doi: 10.1007/s11060-016-2099-8. Epub 2016 Mar 5. J Neurooncol. 2016. PMID: 26945581 Clinical Trial.
Erratum to: Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study.
Chakraborty S, Filippi CG, Wong T, Ray A, Fralin S, Tsiouris AJ, Praminick B, Demopoulos A, McCrea HJ, Bodhinayake I, Ortiz R, Langer DJ, Boockvar JA. Chakraborty S, et al. Among authors: wong t. J Neurooncol. 2016 Jul;128(3):417. doi: 10.1007/s11060-016-2153-6. J Neurooncol. 2016. PMID: 27270719 No abstract available.
Update on glioma biotechnology.
Abrams M, Reichman N, Khatri D, Patel NV, D'Amico RS, Wong T, Fralin S, Li M, Symons M, Langer D, Filippi CG, Boockvar JA. Abrams M, et al. Among authors: wong t. Clin Neurol Neurosurg. 2020 Aug;195:106075. doi: 10.1016/j.clineuro.2020.106075. Epub 2020 Jul 7. Clin Neurol Neurosurg. 2020. PMID: 32653731 Review.
Repeated superselective intraarterial bevacizumab after blood brain barrier disruption for newly diagnosed glioblastoma: a phase I/II clinical trial.
Patel NV, Wong T, Fralin SR, Li M, McKeown A, Gruber D, D'Amico RS, Patsalides A, Tsiouris A, Stefanov DG, Flores O, Zlochower A, Filippi CG, Ortiz R, Langer DJ, Boockvar JA. Patel NV, et al. Among authors: wong t. J Neurooncol. 2021 Nov;155(2):117-124. doi: 10.1007/s11060-021-03851-2. Epub 2021 Oct 3. J Neurooncol. 2021. PMID: 34601657 Clinical Trial.
7,114 results